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Objectives: This report reviews our experience with repeated aortic root replace-
ment after failure of cryopreserved aortic allografts placed during childhood and
compares replacement with aortic allografts, pulmonary autografts, and mechanical
valved conduits in these patients.
Methods: This was a retrospective analysis of all such patients from 1986 through
May 2001.
Results: There were 25 operations (11 aortic allografts, 9 pulmonary autografts, and
5 mechanical valved conduits) among 23 patients. The mean time to reoperation was
6.3 years. There were 2 in-hospital deaths (8%, 1 patient with a pulmonary autograft
and 1 with a mechanical valved conduit). There were 2 early nonfatal valve-related
events (1 patient with an aortic allograft and 1 with a pulmonary autograft). There
were no late valve-related deaths and 2 late non–valve-related deaths of patients
with aortic allografts placed. No variable predicted early death or early valve-related
event. No differences in preoperative characteristics, hospital variables, early out-
comes, or late outcomes were detected among the groups. Overall, 19 patients are
alive (18 in New York Heart Association functional class I and 1 in New York Heart
Association functional class III) at a mean follow-up of 49 months. Two late aortic
allograft failures necessitated reoperation. All patients with successful pulmonary
autografts had excellent autograft function at a mean follow-up of 68 months. All
early survivors with mechanical valved conduits are alive and free of valve-related
events (mean follow-up 71 months). Five-year freedoms from valve-related death or
event (Kaplan-Meier) were 84% for all patients, 91% for aortic allografts, 78% for
pulmonary autografts, and 80% for mechanical valved conduits (no statistically
significant group differences by log-rank test).
Conclusions: Replacement of cryopreserved aortic root allografts placed during
childhood is safe. Five-year pulmonary autograft durability is excellent, although
the risk of early failure may be increased. Differences in 5-year conduit longevity
were not detectable.
The management of aortic valve disease in children is challenging.Multilevel left ventricular outflow tract (LVOT) pathology, addi-tional congenital heart lesions, smaller patient size with growthrequirements, and difficulties with anticoagulation add increasedcomplexity in treating children relative to treating adults. In 1987Clarke and associates1 introduced extended aortic root replacement
with cryopreserved aortic allografts for the treatment of complex LVOT obstruction
in children (Figure 1).2 This procedure combines the concept of aortoventriculo-
plasty previously described by Konno and colleagues3 and Rastan and Koncz4 that
featured total allograft aortic root replacement with direct coronary reimplantation,
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as reported by Somerville and Ross.5 Subsequently, modi-
fied extended aortic root replacement was developed for
patients with severe aortic valve and ascending aortic hyp-
oplasia with or without interrupted aortic arch.6 The modi-
fied procedure combines extended aortic root replacement,
subcoronary closure of the aorta, side-to-side anastomosis
of the ascending aorta to the allograft, and anastomosis of
the distal allograft to the descending aorta. These techniques
enlarge the LVOT, facilitating treatment of annular hyp-
oplasia as required and allowing placement of larger allo-
grafts in small children, providing for somatic growth. Sig-
nificant advantages of allografts particularly important in
children are the low risk of thromboembolism, freedom
from the need for anticoagulation, excellent hemodynamic
performance, low risk of endocarditis, and the range of size
availability. Unfortunately, the longevity of aortic allografts
placed in children has been limited by tissue degeneration
(Figure 2), and reoperation appears inevitable in surviving
patients.7,8
Recent reports indicate that a repeated operation on the
Figure 1. A, Extended aortic root replacement begins with excision of aortic root and preparation of coronary
buttons. B, Oblique incision is made in right ventricle just below pulmonary valve, and this incision is joined by
incision through aortic valve anulus into interventricular septum. C, Aortic root is replaced with aortic allograft
with attached allograft anterior mitral leaflet used to close interventricular septum. D, Right ventricular incision
is closed with separate patch to prevent obstruction. Adapted with permission from Mitchell MB, Campbell DN,
Bishop DA, Clarke DR. Aortic allografts for left ventricular outflow tract replacement in children. In: Williams WG,
editor. Pediatric cardiac surgery annual of the seminars in thoracic and cardiovascular surgery, vol 3. Philadelphia:
WB Saunders; 2000. p. 156, 157, 158, 159.
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aortic root or ascending aorta after previous aortic root
replacement is feasible with acceptable operative mortality
in adult patients.9-12 There are no reports addressing re-
peated aortic root replacement in children who have under-
gone previous aortic root replacement with aortic allografts
or other conduit options. Marked calcific degeneration of
cryopreserved aortic allografts combined with a right ven-
tricular incision and patch enlargement of the infundibulum
introduce difficult technical issues when a repeated aortic
root replacement is required after extended aortic root re-
placement.8
The purposes of this study were to review early and late
results of repeated aortic root replacement after previous
aortic allograft placement in children and to compare the
early and late results of three conduit options used for these
patients: cryopreserved aortic allograft, pulmonary au-
tograft, and mechanical valved conduit.
Methods
Patients
All patients in our center who required explantation of a cryopre-
served aortic allograft previously used for aortic root replacement
and inserted before the age of 18 years were identified. Between
October 1986 and May 2001, a total of 25 repeated aortic root
replacements were performed in 23 patients meeting these criteria.
Two patients underwent third aortic root replacements after place-
ment of a second aortic allograft. For purposes of analysis, fol-
low-up for the first reoperation was terminated at the time of
second allograft explantation for these 2 patients, and the third
aortic root replacement was considered separately. Inpatient and
outpatient medical records of all patients were retrospectively
reviewed. Telephone interviews were conducted with patient fam-
ilies or the patient’s primary care physician. No patients were
unavailable for follow-up. There were 17 male and 6 female
patients. The mean age at reoperation was 12.4  7.4 years, with
a mean interval to reoperation of 6.3 3.9 years. The mean weight
at reoperation was 38.6  23.4 kg. Body weight increased by a
mean factor of 2.2  0.9 between the previous aortic root replace-
ment and reoperation. The initial aortic root replacement was
extended aortic root replacement in 18 cases, modified extended
aortic root replacement in 3 cases, and standard aortic root replace-
ment in 4 cases.
The primary indication for the initial aortic root replacement
was LVOT obstruction in 18 cases, severe aortic insufficiency in 3
cases, truncal valve insufficiency in 1 case, and prosthetic valve
malfunction in 1 case. The mean number of sternotomies before
repeated aortic root replacement was 2.3  0.1. Significant allo-
graft insufficiency was present in 24 cases. Table 1 details the
indications for repeated aortic root replacement. Cases were
grouped according to the three conduit choices used: cryopre-
served aortic allograft, n  l1, pulmonary autograft, n  9, and
Figure 2. Thoracic computed tomographic scan 12 years after previous extended aortic root replacement with
cryopreserved aortic allograft. There is severe allograft calcification. Note proximity of densely calcified RVOT
patch to posterior table of sternum.
Mitchell et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 3 461
CH
D
mechanical valved conduit, n  5. Concomitant procedures were
required in 8 cases (Table 2).
Surgical Technique
Repeated sternotomy was attempted before heparinization in all
cases. Prophylactic peripheral vessel exposure was achieved be-
fore sternotomy in selected cases on the basis of preoperative
radiographic studies. Bicaval and ascending aortic cannulations
were performed, and a left ventricular vent was placed through the
right superior pulmonary vein left atrial confluence. Moderate
hypothermic perfusion with cold blood retrograde cardioplegia
was used in most cases. After cardioplegic arrest, the aorta was
transected at the previous distal suture line, and the allograft was
removed. Coronary buttons were prepared, and all calcified allo-
graft tissue was removed from the buttons. The proximal allograft
valve was excised from the LVOT. In the case of previous ex-
tended aortic root replacement, the ventricular septal defect (VSD)
and right ventricular outflow tract (RVOT) patches were excised
and replaced with polytetrafluoroethylene patches* as required. All
aortic allograft group cases used cryopreserved aortic allografts
(CryoLife, Inc, Kennesaw, Ga), with direct coronary reimplanta-
tion according to previously published techniques.1,8 After disas-
sembly of the aortic root and coronary artery button preparation,
careful autograft procurement was accomplished, and total root
replacement was performed with direct coronary reimplantation in
all pulmonary autograft group cases. The RVOT was reconstructed
with a cryopreserved pulmonary allograft (CryoLife) in all pulmo-
nary autograft group patients. In the mechanical valved conduit
group, St Jude Medical mechanical valved conduits (St Jude Med-
ical, Inc, St Paul, Minn) were used in 4 cases and a Medtronic Hall
valved conduit (Medtronic, Inc, Minneapolis, Minn) was used in 1
case. In the mechanical valved conduit group, direct coronary
button reimplantation was used in 3 cases and the Cabrol modifi-
cation with a polytetrafluoroethylene conduit was used twice.13
Intraoperative transesophageal echocardiography was used in all
cases after 1993.
Definitions and Statistical Methods
Postoperative valve-related mortality and morbidity are reported
according to previously established guidelines.14 Prolonged me-
chanical ventilation was defined as ventilation in excess of 48
hours. Analyses of possible predictors of both early and late
valve-related events were performed with the Cox proportional-
hazards model. Patients who underwent initial modified extended
aortic root replacement were included with those who underwent
extended aortic root replacement for purposes of determining
whether the type of previous aortic root replacement (extended vs
standard) was a risk factor for early death or valve-related event.
Comparisons of categoric variables between groups were done
with the 2 test or the Fisher test, and continuous variables were
compared between groups with the Wilcoxon rank-sum test and
the Kruskal-Wallis test. Early deaths were excluded in the calcu-
lation of hospital length of stay. Freedom from valve-related death
or event was estimated by the Kaplan-Meier method, and compar-
isons among groups were made with the log-rank test. All statis-
tical analyses were performed with S Plus version 4.5 (Mathsoft,
Inc, Seattle, Wash).
Results
Operative Mortality
There were 2 operative deaths in this series, yielding an
operative mortality of 8%. All remaining patients were
discharged alive. Both deaths occurred on the day of oper-
ation. In 1 case the aortic allograft was entered during
resternotomy. Massive hemorrhage occurred, and emer-
gency groin cannulation was complicated by previously
undiagnosed unilateral ileofemoral venous occlusion on the
side of the initial attempt at peripheral cannulation. After
establishment of cardiopulmonary bypass, sternotomy was
completed, and the injury was controlled. A mechanical
valved conduit was inserted, but prolonged hypoperfusion
caused irreversible myocardial injury. The patient could not
be weaned from bypass and died in the operating room. The
second patient underwent a Ross procedure. There were
extensive adhesions in the region of the right ventricular
infundibulum and proximal main pulmonary artery. At the
time of autograft harvest, there was a minimal amount of
infundibular muscle below the pulmonary valve leaflet in-
sertion site adjacent to a heavily calcified RVOT patch that
had been constructed with aortic allograft tissue at the time
of the original extended aortic root replacement. The au-
tograft was inserted, but the proximal autograft suture line
dehisced at this site, causing major hemorrhage after wean-
ing from bypass. The autograft was replaced with an aortic
allograft. The total myocardial ischemic time was 333 min-
utes, and the patient could not be weaned from bypass. A
left ventricular assist device was placed, but the patient died
shortly after transfer to the intensive care unit.
* Gore-Tex, registered trade name of W.L. Gore & Associates, Inc, Flag-
staff, Ariz.
TABLE 1. Indications for repeated aortic root replacement
Indication No.
Severe allograft aortic insufficiency 16
Combined allograft aortic insufficiency and aortic
stenosis
8
Severe allograft aortic stenosis 1
TABLE 2. Concomitant procedures
Procedure No.
Pulmonary allograft RVOT repeated replacement 1
Patch closure of LVOT pseudoaneurysm 1
Aortic arch replacement 1
Closure of residual VSD 1
Aortic anulus plication 1
Placement of left ventricular assist device 1
Epicardial to endocardial pacer conversion 1
Splenectomy for abscess 1
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Operative and Hospital Courses
Resternotomy was accomplished uneventfully in 21 of 25
cases. There were 2 aortic injuries resulting in 1 operative
death, as noted previously. Emergency peripheral cannula-
tion without previous peripheral vessel exposure was re-
quired in both of these cases. Prophylactic peripheral vessel
exposure was performed before sternotomy in 3 cases, and
peripheral cannulation was required in 2 of these cases after
densely adherent RVOT patches were disrupted. The mean
cardiopulmonary bypass time was 254 minutes (range 108-
757 minutes). The mean total aortic occlusion time was 135
minutes (range 49-333 minutes).
No patient required reoperation for bleeding, and there
were no conduction tissue injuries. Thirteen patients had no
complications. Excluding the 2 early deaths, 13 complica-
tions occurred in the remaining 10 cases (Table 3). Four
major nonfatal complications occurred in 3 patients. One
patient had aortic allograft entry during resternotomy, as
described previously, and survived without adverse se-
quelae. One patient had early autograft insufficiency neces-
sitating reoperation. One patient had mediastinitis necessi-
tating operative de´bridement, and allograft endocarditis
subsequently developed and was treated medically. The
median hospital stay of survivors was 8 days, and 17 pa-
tients were discharged within 10 days.
Pathology
At the time of surgery, porcelainlike allograft walls and
valve leaflets with densely calcified excrescences were
present in most cases. Pathologic reports were available for
22 of the 25 explanted aortic allografts. In 20 cases, devi-
talized elastic tissue with mural allograft calcification and
fibrosis were identified histologically. Few or no inflamma-
tory cells were noted in all these cases. In the remaining 2
cases, heavy inflammatory cell infiltrates were present. One
4-month-old infant required reoperation 4 months after
modified extended aortic root replacement because of se-
vere allograft insufficiency and distal allograft stenosis. The
allograft cusps were pliable, but there was central absence
of leaflet coaptation. Histologic examination revealed no
calcification and a dense non–T cell lymphocytic infiltrate.
In the remaining case, Candida tropicalis allograft endocar-
ditis and a residual VSD necessitated repeated extended
aortic root replacement 4 months after the previous opera-
tion. Leaflet vegetations with no evidence of calcification
were noted at operation. Pseudohyphae and dense inflam-
matory cell infiltrates without calcification were identified at
histologic examination.
Early Failure of Replacement Valves
Three early valve failures occurred. Intraoperative disrup-
tion of the proximal autograft suture line occurred in 1 case,
resulting in early death as noted previously. A patient un-
dergoing the Ross procedure had moderate autograft insuf-
ficiency that was detected on postoperative day 3. Intraop-
erative transesophageal echocardiography had demonstrated
only trace autograft insufficiency. Moderate autograft insuf-
ficiency persisted, and replacement with an aortic allograft
was performed on postoperative 6. At reoperation, no struc-
tural autograft damage was identified, but the entire au-
tograft was markedly edematous. This patient recovered
uneventfully. In the third case, early allograft endocarditis
was diagnosed on postoperative day 24. This child was born
with truncus arteriosus and underwent total repair with a
pulmonary allograft RVOT reconstruction, a subsequent
standard allograft aortic root replacement after the develop-
ment of truncal valve insufficiency, and a third operation for
replacement of the pulmonary allograft inserted at the initial
total repair. At the time of repeated aortic root replacement,
bilateral outflow tract replacements with allografts were
performed. The patient had mediastinitis necessitating op-
erative de´bridement and antibiotic therapy. The child sub-
sequently had Candida albicans septicemia with aortic in-
sufficiency, and a presumptive diagnosis of endocarditis
was made. Further reoperation was refused, and the child
was treated intravenously with amphotericin B. The child
survived and is currently in New York Heart Association
(NYHA) functional class III with severe aortic allograft
insufficiency at 48 months of follow-up.
According to univariable analysis, age, weight, type of
original aortic root replacement, conduit type at repeat aor-
tic root replacement, interval to reoperation, number of
previous sternotomies, cardiopulmonary bypass time, and
aortic occlusion time were not predictive of early death or
early valve-related event. Only cardiopulmonary bypass
time approached statistical significance (P  .09).
Group Variables
Characteristics of the three operative groups are given in
Table 4. Although there were no detectable differences in
preoperative or operative variables among groups at the
95% confidence level, the small number of patients in each
TABLE 3. Complications among survivors
Complication No.
None 13
Prolonged ventilation 3
Cardiovascular injury during resternotomy 3
Pulmonary artery injury requiring reconstruction 1
Protamine reaction 1
Early reoperation (autograft failure) 1
Early allograft endocarditis 1
Mediastinitis 1
Renal insufficiency 1
Delayed pneumothorax 1
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group limits the ability to distinguish differences, and actual
differences among groups cannot be excluded.
Late Deaths and Valve-Related Events
There were no late valve-related deaths in any group. There
were 2 late deaths in the aortic allograft group (Table 5,
patients 1 and 7). Autopsies revealed no evidence of valvu-
lar dysfunction in either case. There were no late deaths in
the pulmonary autograft and mechanical valved conduit
groups. There were 2 late valve failures in the aortic allo-
graft group, each necessitating a third aortic root replace-
ment (Table 5, patients 2 and 5). There have been no late
valve failures or valve-related events in the pulmonary
autograft and mechanical valved conduit groups. Age at
reoperation, weight, type of original aortic root replace-
ment, conduit type at repeated aortic root replacement,
interval to reoperation, and number of previous sternoto-
mies were not predictive of late valve-related events.
Late Outcomes
Nineteen of the 23 patients are alive (Table 5). Eighteen
patients are in NYHA class I, and 1 patient is in NYHA
class III. The mean follow-up time for all patients was 49
months. The 5-year estimated freedom from valve-related
death or event for the entire series was 84% (Figure 3).
Excluding operative deaths, the 5-year freedom from valve-
related death or event was 91% for the entire series. Mean
follow-up times for the aortic allograft, pulmonary au-
tograft, and mechanical valved conduit groups were 42, 53,
and 57 months, respectively. The 5-year estimated freedoms
from valve-related death or event for the aortic allograft,
pulmonary autograft, and mechanical valved conduit groups
were 91%, 78%, and 80%, respectively. No differences in
estimated freedoms from valve-related death or event were
detected among the three groups (Figure 4).
Of 10 patients in the aortic allograft group (11 opera-
tions), 8 are alive. As noted previously, 1 of these patients
was later treated with a third allograft and 1 patient under-
went subsequent conversion to a mechanical valve. Thus 7
repeated allografts are currently under follow-up in the
aortic allograft group. One patient is in NYHA class III after
early development of endocarditis (postoperative day 24)
and remains alive without operation, as noted previously. Of
the remaining 6 patients in the allograft group, all are in
NYHA class I at a mean follow-up of 46 months. Echocar-
diographic examination of allograft function has revealed
trace or no allograft insufficiency in 3 cases, mild insuffi-
ciency in 2 cases, and mild insufficiency with mild stenosis
in 1 case.
All pulmonary autograft group survivors remain alive in
NYHA class I. All patients discharged after successful Ross
procedures (n  7) have stable autograft function at a mean
follow-up of 68 months. On echocardiography, 2 autografts
have trace insufficiency, 4 have mild insufficiency, and 1
has mild insufficiency and mild stenosis. There have been
no RVOT allograft replacements among the 7 patients who
had successful Ross procedures. The other surviving patient
who required early autograft replacement with an aortic
allograft has normal valve function at 49 months of fol-
low-up but required RVOT allograft replacement at 12
months for severe pulmonary insufficiency.
The 4 mechanical valved conduit group patients who
survived reoperation remain alive in NYHA class I. There
have been no late valve-related complications in the me-
chanical valved conduit group at a mean follow-up of 71
months.
Discussion
There is no ideal solution for children requiring primary
aortic valve replacement. After the introduction of the ex-
tended aortic root replacement technique, allograft replace-
ment of the aortic valve became a commonly used option in
many pediatric centers. Follow-up now indicates that sur-
viving children will inevitably require reoperation.8 The
current series demonstrates that reoperation after previous
allograft standard or extended aortic root replacement per-
TABLE 4. Group variables
Aortic allograft
group (n  11)
Pulmonary autograft
group (n  9)
Mechanical valved
conduit group (n  5)
Age (y) 10.2 (0.3-19.3) 13.0 (3.9-23.4) 16.1 (3.3-23.3)
Weight (kg) 31.8 (4.0-67.8) 39.3 (15.0-70.3) 52.5 (11.0-81.0)
Previous sternotomies 2.0 (1.0-4.0) 2.2 (1.0-3.0) 3.2 (2.0-5.0)
Interval to reoperation (y) 5.9 (0.2-12.7) 6.7 (3.3-12.6) 6.3 (3.1-11.6)
Explanted allograft size (mm) 16.5 (11.0-22.0) 18.4 (12.0-22.0) 19.4 (13.0-22.0)
Cardiopulmonary bypass time (min) 206 (108-315) 286 (166-757) 282 (149-403)
Aortic occlusion time (min) 114 (58-158) 169 (98-333) 119 (49-225)
Median hospital stay (d) 11 (4-49) 5.5 (4-13) 8 (5-11)
Total early deaths (No.) 0 (0%) 1 (11%) 1 (20%)
Total early valve failures (No.) 1 (9%) 1 (11%) 0 (0%)
All values reported as mean and range unless number of patients is indicated.
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TABLE 5. Patient outcomes
Case Sex
Age at previous
operation (y) Indication for reoperation
Age at
reoperation
(y) Outcome
Aortic allograft group (n  11)
1 F 0 (neonatal) Allograft endocarditis, aortic
insufficiency
0.3 Non-valve-related late death at 11.9 mo
2* F 1 Allograft aortic insufficiency 1.7 Valve failure at 96.3 mo; reoperation third
aortic allograft
5† M 14.7 Allograft endocarditis, aortic
insufficiency, residual VSD
15.1 Valve failure at 73.0 mo, reoperation with
mechanical valved conduit
7 M 0.003 Allograft aortic insufficiency 0.3 Non-valve-related late death at 2.3 mo
8 M 6.5 Allograft endocarditis, aortic
insufficiency
13.7 Mild aortic insufficiency and mild aortic
stenosis at 86.4 mo
9 M 11.5 Allograft aortic insufficiency 19.3 Mild aortic insufficiency at 60.7 mo
14 M 2 Allograft aortic insufficiency 10.9 No aortic insufficiency at 52.1 mo
15* F 1.7 Allograft aortic insufficiency 9.7 Mild aortic insufficiency at 49.7 mo
16 M 0.5 Allograft aortic insufficiency,
allograft pulmonary
insufficiency
9.7 Valve failure endocarditis at 0.8 mo, severe
aortic insufficiency at 44.2 mo
24 F 6.6 Allograft aortic insufficiency 16.8 No aortic insufficiency at 2.7 mo
25 M 2.3 Allograft aortic stenosis, aortic
insufficiency, arch obstruction
15 Trace aortic insufficiency at 1.4 mo
Pulmonary autograft group (n  9)
4 M 0.6 Allograft aortic insufficiency,
mild aortic stenosis
3.9 Mild neoaortic insufficiency, mild
pulmonary stenosis and pulmonary
stenosis and pulmonary insufficiency at
125.1 mo
6 M 0.3 Allograft aortic insufficiency,
mild aortic stenosis
4.1 Mild neoaortic insufficiency and neoaortic
stenosis, moderate pulmonary
insufficiency and pulmonary stenosis at
115.2 mo
10 M 3.7 Allograft aortic insufficiency,
aortic stenosis
8.2 Trace neoaortic insufficiency, moderate
pulmonary insufficiency, mild pulmonary
stenosis at 58.2 mo
11 M 4.4 Allograft aortic insufficiency 8.1 Early reoperation at 0.2 mo for neoaortic
insufficiency
12 M 9.8 Allograft aortic stenosis 14.4 Mild neoaortic insufficiency, moderate
pulmonary stenosis, mild pulmonary
insufficiency at 54.7 mo
17 M 5.8 Allograft aortic insufficiency 11.5 Mild neoaortic insufficiency, mild
pulmonary insufficiency at 43.0 mo
20 M 12.8 Allograft aortic insufficiency 23.4 Trace neoaortic insufficiency, moderate
pulmonary stenosis at 33.9 mo
22 F 8 Allograft aortic insufficiency,
mild aortic stenosis
20.6 Mild neoaortic insufficiency, trace
pulmonary insufficiency at 10.4 mo
23 M 11 Allograft aortic insufficiency,
mild aortic stenosis
22.6 Intraoperative death
Mechanical valved conduit group (n  5)
3 M 0.2 Allograft aortic insufficiency 3.3 Normal valve function at 126.9 mo
13 F 10.2 Allograft aortic insufficiency,
pseudoaneurysm
14.2 Normal valve function at 53.6 mo
18† M 15.1 Allograft aortic stenosis, aortic
insufficiency
21.1 Mild subvalvular stenosis at 42.5 mo
19 F 12.2 Allograft aortic insufficiency 18.8 Normal valve function at 41.4 mo
21 M 11.7 Allograft aortic stenosis,
moderate aortic insufficiency
23.3 Intraoperative death
Patients are listed chronologically by group.
*Indicates same patient.
†Indicates same patient.
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formed for congenital LVOT disease can be accomplished
with good results, considering the inherent complexity in
this patient population. Most centers, including our own,
now favor the pulmonary autograft whenever feasible for
children requiring initial aortic valve replacement. The pos-
sibility of autograft growth provides the potential for a
lifelong aortic valve replacement that may obviate the need
for complex reoperations on the aortic root.15 However, the
true longevity of the pulmonary autograft in children is
unknown.
The overall in-hospital mortality of 8% in this series is
comparable to reports of repeated aortic root replacement in
adults, with mortality rates ranging from 3% to 9%.9-12,16-18
Excluding the 2 operative deaths, the 5-year freedom from
valve-related death or event was 91%. This series focused
on reoperative aortic root replacement in patients whose
initial aortic root replacement was performed for congenital
LVOT disease, and all patients had undergone previous total
allograft aortic root replacement. To our knowledge there
are no other published reports concerning similar patients.
Furthermore, no other series has included patients with
previous extended aortic root replacement.
Yacoub’s group9 published the only previous article con-
centrating solely on patients undergoing repeated aortic
valve operations after previous total allograft aortic root
replacement. Those authors found it possible to perform
either mechanical valve replacement or subcoronary allo-
graft replacement within the old allograft conduit in 13 of
22 cases. Because of the porcelainlike allografts frequently
encountered, and in some cases size constraints or the
presence of active endocarditis, we have not found simple
valve insertion (mechanical or subcoronary allograft) feasi-
ble in any case. It is possible that either differences in
allograft preparation or differences in the response of chil-
dren to allograft tissue may account for this difference.7
Only cryopreserved allografts were used in our patients, in
contrast to the fresh, antibiotic-sterilized or “homovital”
allografts used by Yacoub’s group.9 Two additional reports
from this group11,19 contain patient subpopulations under-
going repeated replacement of the aortic valve after previ-
ous allograft aortic valve replacement; however, it is not
clear how many (if any) patients had undergone initial total
aortic root replacement rather than subcoronary valve im-
plantation.11,19
The 2 in-hospital deaths in our series were entirely at-
tributable to technical issues. Others have emphasized the
necessity for safe sternal reentry, and our experience further
underscores this point.10,12 RVOT patch presence increases
the risk of right ventricular entry when the previous opera-
tion was an extended aortic root replacement. Some authors
have advocated routine peripheral cannulation.16 However,
this strategy has several disadvantages in children. The size
Figure 3. Kaplan-Meier estimated freedom from all valve-related death or event for 25 repeated aortic root
replacements performed on 23 patients. Vertical lines indicate censored data.
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of the femoral vessels in children often necessitates small
cannulas that limit perfusion capacity, and vessel injury is
also more problematic. Many children have had multiple
previous catheterizations at very young ages, producing
ileofemoral occlusion. In addition, most patients will re-
quire future catheterizations or reoperations, and peripheral
vascular access should be preserved. Furthermore, these
operations require lengthy cardiopulmonary bypass times,
which are significantly extended when bypass is instituted
before sternotomy. Lateral chest radiographic findings have
been used to assess the safety of sternal reentry. Unfortu-
nately, the retrosternal space of the patient who died of
aortic injury during sternal reentry appeared adequate for
safe resternotomy. Thoracic computed tomographic scan-
ning is now used routinely to assess the proximity of the
aorta and the RVOT to the posterior sternal table (Figure 2).
Also, ileofemoral arterial and venous patency is routinely
assessed before operation by either catheterization or duplex
ultrasonography in all cases. Prophylactic iliac or femoral
vessel exposure is achieved before sternotomy in patients
deemed at high risk for cardiac or great vessel injury. With
this strategy, cardiopulmonary bypass was easily and
quickly established in both cases in which right ventricular
injury occurred. Establishment of cardiopulmonary bypass
with deep hypothermic circulatory arrest before sternotomy
should be considered when the risk of aortic entry appears
high on the basis of computed tomographic findings.10,17
Finally, polytetrafluoroethylene membrane pericardial sub-
stitute reduces the risk of cardiac and great vessel injuries at
resternotomy and is now placed to reduce the risk of future
reoperations.
Few data are available concerning the safety of convert-
ing a failed aortic allograft to a pulmonary autograft. A
series by Carr-White and coworkers19 contains patients who
underwent pulmonary autograft aortic root replacement af-
ter previous allograft aortic valve replacement. There were
no early deaths and no autograft failures. However, the
length of follow-up and the number of patients, if any, with
previous total aortic root replacement rather than subcoro-
nary allograft implantation were not specified. Conversion
to a pulmonary autograft was successful in 7 of 9 cases in
our series, and autograft function has been excellent in these
7 patients at a mean follow-up of 68 months. Two of our
patients underwent Ross procedures at 4 years of age and
have had excellent autograft function without RVOT reop-
eration for more than 9 years. However, the risk of early
autograft failure may be increased. In our experience this
problem has not been encountered in patients with previous
operations other than extended aortic root replacement. Au-
tograft harvesting is more difficult in the presence of a
Figure 4. Kaplan-Meier estimated freedom from all valve-related death or event for reoperations with aortic
allografts (group AA), pulmonary autografts (group PA), and mechanical valved conduits (group MV). There were
no statistically significant differences among groups (log-rank test). Vertical lines indicate censored data.
Mitchell et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 3 467
CH
D
heavily calcified and densely adherent aortic allograft, but
autograft injury can usually be avoided by enucleating the
autograft without attempting to separate densely adherent
allograft tissue. In patients who have had previous extended
aortic root replacement, the presence of a heavily calcified
or prosthetic RVOT patch in close proximity to the hinge
point of the right facing and anterior pulmonary leaflets may
not permit an adequate muscular cuff to allow safe use of
the autograft. The second death that occurred in our series
was from this cause, and careful assessment of the quality of
the tissue before committing to the use of the autograft is
essential. The etiology of early postoperative autograft fail-
ure in our case that required early reoperation is unclear.
Intraoperative function was excellent according to trans-
esophageal echocardiography, and the marked autograft
edema noted at reoperation remains unexplained. This pa-
tient had previously undergone pulmonary artery banding
followed by VSD closure with band removal and pulmonary
artery reconstruction, with a subsequent operation to close a
residual VSD, all before the initial extended aortic root
replacement. It is possible that previous interventions on the
pulmonary artery may have influenced the quality of the
autograft. However, a similar patient who underwent pul-
monary artery banding followed by band removal with
pulmonary artery reconstruction and then extended aortic
root replacement (Table 5, patient 22) had successful con-
version to a pulmonary autograft with stable valve function
15 months after a Ross procedure.
There were no predictors of early death or valve failures
found among our patients. No predictors of late valve-
related events were identified. The retrospective design and
relatively small number of patients are significant limita-
tions of the study. The latter problem is magnified for group
comparisons. Despite the lack of statistical differences in
late outcomes for the three conduit options, we believe that
the curve shapes are clinically relevant and that differences
will probably emerge with longer follow-up (Figure 4).
There is a late decline in freedom from valve-related events
in the aortic allograft group, whereas the curves for the
pulmonary autograft and mechanical valved conduit groups
remain flat after the early postoperative period. The decline
in freedom from valve-related death or event for the aortic
allograft group is primarily due to late allograft degenera-
tion. This finding is similar to what we have observed in
patients undergoing first-time allograft aortic root replace-
ment.8 Consequently, pulmonary autograft and mechanical
valve longevity may prove superior with further follow-up.
Recently the pulmonary autograft has been favored for
reoperative patients. Before 1996, aortic allografts were
used in 6 cases, pulmonary autografts were used in 2 cases,
and a mechanical valved conduit was used in 1 case. Since
1996, pulmonary autografts have been used in 7 of 16 cases,
with aortic allografts and mechanical valved conduits used
in 5 and 4 cases, respectively. Although differences in age
and size among groups were not apparent, this finding was
probably due to the low number of patients in the mechan-
ical valved conduit group. Mechanical valves have been
used primarily in older patients, in whom anticoagulation is
more easily managed.
Conduit selection should be individually tailored. Impor-
tant considerations include age, sex, medical compliance,
ventricular function, presence of infection, previous surgical
procedures, physical activity, and patient preference. Allo-
grafts remain an option for patients who desire to avoid
anticoagulation and in whom either a pulmonary autograft is
not feasible or the potential increased risk of early autograft
failure is not acceptable. If a pulmonary autograft is chosen,
intraoperative findings must ultimately determine whether
this option is feasible. Our current practice is to attempt
conversion to a pulmonary autograft for patients who are
likely to have significant future growth and in whom there
is a strong reason to avoid anticoagulation, provided that
intraoperative findings allow safe harvesting of the au-
tograft. Repeated aortic allografts are reserved for patients
with active endocarditis and patients with a strong reason to
avoid anticoagulation but with preoperative or intraopera-
tive findings contraindicating pulmonary autograft. Me-
chanical valved conduits are favored for patients in whom
anticoagulation is acceptable and in whom intraoperative
difficulties suggest that this option is the most expeditious
means of achieving a safe outcome.
In summary, patients with failed allograft aortic root
replacements represent a particularly challenging group.
However, our results indicate that repeated aortic root re-
placement can be accomplished with relative safety after
previous standard or extended aortic root replacement with
a cryopreserved aortic allograft during childhood. Conse-
quently, patients with failed allograft aortic root replace-
ments should undergo reoperation before deterioration of
ventricular dysfunction further complicates the procedure.
We have not found simple valve insertion within a failed
allograft to be an option in these cases. No differences in
5-year conduit longevity were detectable among the treat-
ment options. With more patients and longer follow-up,
differences are likely to emerge. Late allograft degeneration
will probably necessitate further reoperation. Pulmonary
autografts are technically more demanding, and there may
be an increased risk of early autograft failure in patients
who have had previous extended aortic root replacement.
However, 5-year autograft function has been stable after
successful conversion to a pulmonary autograft.
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Discussion
Dr John Hawkins (Salt Lake City, Utah). Dr Mitchell gave an
excellent presentation this morning. This group in Denver is to be
commended for their excellent results with what I consider one of
the more difficult groups of patients that we have to deal with in
pediatric cardiac surgery.
The material presented today offers the latest chapter in an
ongoing story that this group has been writing, examining the use
of the aortic allograft for reconstruction of congenital LVOT
obstruction. This is intimately intertwined with the history of The
Western Thoracic Surgical Association, and the first chapter was
presented here 15 years ago in 1986, when Drs Clarke and Camp-
bell and colleagues in Denver first described the use of the ex-
tended aortic root replacement combining cryopreserved allograft
aortic root replacement with a Konno-type aortoventriculoplasty in
children. The second chapter in this story was presented here 9
years ago at The Western Thoracic Surgical Association in 1992,
when the group warned us of the rapid deterioration of aortic
allografts in young recipients. The latest chapter, which Dr Mitch-
ell has presented here today, tells us what to expect in terms of
short-term and intermediate-term results when replacement of this
aortic root allograft needs to be done, and it looks at three different
valve replacement options. Although Yacoub’s group has de-
scribed a similar group of reoperations, these primarily have been
in adults, and I believe that this is probably the first series of aortic
root allograft replacements recorded in the pediatric age group.
There were a total of 25 repeated operations in 23 patients with
2 operative deaths and 2 late deaths, and the long-term actuarial
freedoms from death or valve-related events were similar in all
three of the treatment options. I have a number of questions.
Dr Mitchell, in the article and the presentation, all the patients
but 1 were noted to have severe aortic valve insufficiency at the
time of reoperation. I think that 3 or 4 of the patients also had
severe aortic allograft stenosis, but in general aortic valve insuf-
ficiency was the predominant lesion, and most of the patients did
not seem to outgrow their valves. Given the difficulty of quanti-
fying aortic insufficiency, particularly in children, the fact that
children often can go many years with moderate degrees of aortic
valve insufficiency, and the formidable nature of aortic root re-
placement, how did you decide when to replace these aortic root
allografts? What were your specific indications in terms of aortic
insufficiency to replace these allografts?
Dr Mitchell. The honest answer is that it has been a fairly
subjective decision. The reality is that most of these patients have
had some ventricular dysfunction develop by the time that we have
seen them. Largely that has been because the cardiologists have
recognized what a formidable group of patients they are and have
had the tendency to want to hold back on reoperation in these
patients longer than I think should be done. As we have demon-
strated, reoperation can be done safely. I really cannot give you a
direct answer, other than to say that most other patients have had
indications comparable to the indications that we would use in
cases of native aortic valve disease.
Dr Hawkins. In Dr Clarke’s presidential address, he told us
that many of these allografts were taken out piecemeal and that he
did not possess enough tissue to furnish us with a picture. We are
all aware of the emerging role of immunology in the destruction of
these grafts, and we know about the role of calcification and
perhaps structural deterioration. Do you have any further data or
perhaps insight regarding the pathology in the explanted valves?
Dr Mitchell. We do not have immunologic analyses per se. In
22 of the 25 cases we had the pathologic descriptions, both
intraoperative and microscopic. In the vast majority of cases there
was severe calcification and fibrosis, with little evidence of any
viable tissues other than inflammatory cells in a couple of cases.
There were 2 cases in which there was no calcification, and in
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those 2 cases there were inflammatory infiltrates. One of these
patients had candidal endocarditis. We saw pseudohyphae and
inflammatory cells. The other case was one of the early cases
where it was recognized that very young children probably have a
different response to allograft tissue, and that was a child who had
her reoperation at the age of 3 months. She already had aortic
insufficiency, and at that time there was no calcification but there
was a non–T-cell lymphocytic infiltrate. This case occurred 12
years ago. No other patients in that young age group have since
presented the opportunity to do further sophisticated testing of
their pathologic specimens.
Dr Hawkins. The largest group in your division into three
groups was the group that had repeated aortic allograft root inser-
tion. These also tended to be in the youngest patients. Given the
previous warnings of your group regarding aortic allografts in
young patients, why did you decide to replace the failing aortic
allograft with another?
Dr Mitchell. I think that decision has to be made on an
individual basis. I would say that there has been an evolution
toward doing the Ross procedure, and in fact in the last 5 years we
have done more Ross procedures in these patients than any other
conduit. However, some of these children have active infection, for
example, and to add to what is already an extremely difficult case
I think would increase the risk. In some cases the pulmonary
arteries had been operated on previously. There were a couple of
children who had pulmonary artery bands and had then gone back
and had pulmonary artery reconstructions. We have actually done
Ross procedures in a couple of these patients, 1 of whom was
among those with early failure. It is just a much more difficult
scenario. There was also 1 patient who was born with truncus
arteriosus, so the Ross procedure was not an option.
Dr Hawkins. Finally, among the 9 patients who underwent
pulmonary autograft procedures, there were 2 early failures, both
in patients who had previously undergone extended aortic root
replacement. Do you consider a previous aortic root replacement
with a Konno-type aortic ventriculoplasty to be a relative contra-
indication to doing the pulmonary autograft procedure or just a
warning to be more careful in how the autograft is harvested and
implanted?
Dr Mitchell. I think it is not a contraindication, but it certainly
requires increased discussion with the family in the already diffi-
cult situation of choosing a conduit. The bottom line is that the
decision has to be made in the operating room. In the case of the
patient who died during the operation, we probably should not
have proceeded with the Ross procedure. The other case is still a
mystery to us. That child had excellent intraoperative function, and
when we explanted the autograft the entire thing was edematous,
although we could not see any structural surgical damage to the
autograft. That patient had a previous pulmonary artery band and
reconstruction, so I think that perhaps you have to look at the
number of procedures that have been done on the pulmonary artery
itself previously and then also see how much adhesion and intra-
operative difficulty you encounter, because in some of these cases
it has not been that difficult to get the autograft out.
Dr Hawkins. Dr Mitchell, you and your group are to be
commended for furthering our understanding of aortic root allo-
grafts in children and on your presentation today and your excel-
lent results.
Dr F. Mark Lupinetti (Seattle, Wash). I also congratulate you
on your outstanding results with these very challenging operations.
They are always quite difficult, but I notice that in your series you
describe doing a repeated root replacement I believe in all the
cases.
Dr Mitchell. That is correct.
Dr Lupinetti. I wonder if you would consider the classic
inclusion technique, because we have found that in these repeated
allograft situations it is often quite a bit easier. Especially in the
presence of insufficiency, which was the predominant pathologic
lesion, an inclusion technique can be done easily and perhaps
somewhat more safely, especially when there is concern regarding
hemorrhage, dehiscence, or other related problems. Have you ever
considered that, or do you think that the root replacement should
always be performed?
Dr Mitchell. Can you clarify whether you are referring to the
primary or the secondary operation?
Dr Lupinetti. I mean the second operation, after the allograft
has failed.
Dr Mitchell. At least in my experience, and I have helped with
maybe 6 of these, I would like to see that done, but I do not see
how we could have sewn to this tissue. Most of them have required
extensive de´bridement to have anything to sew to, so although I do
not say that is not possible, it certainly seems difficult from what
I have seen.
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